Long-acting antibodies (investigational)

· Spyre Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Long-acting antibodies (investigational), covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis [Phase 2]